Home SixPeaks Bio

SixPeaks Bio

acquired
Series A
Weight Loss Drug Developer
Basic
Enterprise Profile

Basic Information

SixPeaks Bio is developing a series of first-class drugs for healthy weight loss. The SixPeaks team leverages Ridgeline's in-house biologics capabilities to develop an IIA/B receptor-activating antibody that effectively preserves human skeletal muscle mass.
SixPeaks Bio AG
Basel,CantonofBasel-City,Switzerland
unclear
January 01, 2022
--
--

Enterprise Profile

Industrial Sector
New Drug Development
Technology
Biotechnology
Concept
Obesity
Application Scenarios
Innovative Drugs